{
  "trial_id": "NCT01775501",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Histologically confirmed advanced HCC",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Barcelona Clinic Liver Cancer stage C or stage B if you cannot tolerate or failed TACE",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No cirrhosis or Child-Pugh A cirrhosis",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Measurable lesions",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "All acute toxic effects of any prior treatment have resolved to NCI-CTCAE v4.0 grade 1 or less",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Able to swallow and retain oral medication",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Prior systemic regimens for HCC",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Uncontrolled hypertension",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "CLIP score > 3",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "ECOG PS > 1",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient has history of acne and mild hirsutism, elevated testosterone levels, gradual enlargement of hands and feet, irregular menstrual cycle, nipple discharge, snoring, headache, facial features of acromegaly and prognathism. Laboratory evaluation reveals IGF-1 of 968 ng/mL and random GH of 19.7 ng/mL.",
  "_meta": {
    "topic_id": "20",
    "trial_id": "NCT01775501",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}